OPTI logo

Optimi Health Corp. Stock Price

CNSX:OPTI Community·CA$38.8m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

OPTI Share Price Performance

CA$5.90
0.95 (19.19%)
CA$5.90
0.95 (19.19%)
Price CA$5.90

OPTI Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Slight risk with mediocre balance sheet.

4 Risks
1 Reward

Optimi Health Corp. Key Details

CA$231.9k

Revenue

CA$424.7k

Cost of Revenue

-CA$192.8k

Gross Profit

CA$5.2m

Other Expenses

-CA$5.4m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
-0.96
-83.17%
-2,330.08%
180.8%
View Full Analysis

About OPTI

Founded
2020
Employees
8
CEO
Dane Stevens
WebsiteView website
www.optimihealth.ca

Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada. The company manufactures controlled substances including finished MDMA and psilocybin drug products, supplying them directly to authorized clinics, pharmacies, clinical trials, and partners. The company produces and supplies MDMA, natural psilocybin, psilocin, other psychedelic substances, and functional mushrooms derived from botanical sources for health and wellness markets. The company also engages in farming, processing, and distribution of raw mushroom biomass, mushroom extracts, manufacturing of drug products, and mushroom supplements. It sells its products through Amazon marketplace and distributors/brokers, as well as online. Optimi Health Corp. was incorporated in 2020 and is based in Princeton, Canada.

Recent OPTI News & Updates

Analysis Article Jun 12

Why Optimi’s Ibogaine Initiative Could Open a New Growth Channel

Optimi Health advances ibogaine strategy amid rising regulatory and research support.

Recent updates

No updates